Perry, Manuel

Perry, Manuel was paid $102K by Medicaid between Mar 2019 and Nov 2024, across 5 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 63% of everything it billed.

33Billing provider infoPERRY, MANUEL
MIDDLETOWN, NY 10941

33aNPI1982691648assigned 09/28/2005

33bProvider typeMedical Oncology Physician

28Total paid$102K

24GClaims3,240

24DCodes billed5

24AFirst – last monthMar 2019 – Nov 2024

Compared with peers

Next to other Medical Oncology Physician providers in New York

Rank by total paid#4 of 84

Median peer was paid$6K

This provider vs. median16×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2019	229	$5K
2020	561	$19K
2021	1,057	$32K
2022	862	$32K
2023	337	$9K
2024incomplete	194	$4K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	63%	1,069	804	$64K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	32%	716	678	$33K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	3.6%	654	492	$4K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.3%	15	13	$1K
36415	Collection of venous blood by venipuncture	<1%	786	564	$103.76

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.